STOK Stoke Therapeutics, Inc.
24.29USD-0.33%Mkt Cap: 1.57B $P/E: —1d ago
Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) …
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap1.57B USD
Enterprise Value1.28B USD
Revenue (TTM)27.59M USD
Gross Profit27.59M USD
Net Income (TTM)-6.88M USD
Revenue/Share0.44 USD
Last Price24.29 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees170
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.93
PEG—
EV/EBITDA-5.79
EV/Revenue46.48
P/S57.00
P/B4.40
EPS (TTM)-3.38
EPS (Forward)-3.52
52W Range
20.3220% of range40.22
52W High40.22 USD
52W Low20.32 USD
Profitability
Gross Margin100.00%
Oper. Margin-701.65%
EBITDA Margin0.00%
Profit Margin-3.73%
ROE-1.95%
ROA-1.65%
Growth
Revenue Growth-32.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF45.59M USD
CapEx (TTM)670.00K USD
FCF Margin-384.96%
FCF Yield-6.78%
Net Debt-290.14M USD
Net Debt/EBITDA1.31
Balance Sheet
Debt/Equity0.01
Current Ratio7.69
Quick Ratio7.19
Book Value/Sh5.54 USD
Cash/Share4.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)46.46 USD
Upside (mean)+91.3%
Target Range35.00 USD – 60.00 USD
35.00+91.3% to mean60.00
# Analysts13
Ownership
Shares Out.64.53M
Float45.61M
Insiders3.68%
Institutions125.32%
Short Interest
Short Ratio13.7d
Short % Float17.95%
Short % Out.17.28%
Shares Short11.15M
Short (prev mo.)12.98M
Technical
SMA 5029.82 (-18.6%)
SMA 20031.61 (-23.2%)
Beta1.26
S&P 52W Chg16.45%
Avg Vol (30d)763.97K
Avg Vol (10d)1.17M
Technical Indicators
RSI (14)29.2
MACD-1.5316
MACD Signal-1.3439
MACD Hist.-0.1876
BB Upper31.31 USD
BB Middle27.14 USD
BB Lower22.96 USD
BB Width30.80%
ATR (14)1.313 USD
Vol Ratio (20d)0.68x